$0.515
-0.021 (-4.15%)Zum Schluss
AMST-News
AMST-Events
Amesite Launches New Sales Model, NurseMagic Enterprise Priced at $1,099 per Month
Amesite announced a new sales win with its minimum enterprise pricing model, providing additional commercial validation for a model designed to serve post-acute care organizations across a broad range of operating sizes while supporting attractive unit economics and scalable revenue growth. Under the new model, NurseMagic Enterprise is priced at $1,099 per month for organizations with patient census up to 1,000 under a 12-month contract. Amesite estimates annual agreements at this level provide approximately 85% gross margin, establishing meaningful contract value at smaller census levels while preserving greater revenue opportunity as deployment size increases.
Amesite Files Prospectus for Resale of 4.84M Shares
Amesite filed a prospectus relating to the resale by selling shareholders, from time to time, of up to 4.84M shares of common stock.
Amesite Issues 696,866 Shares at $1.435 Each
Amesite announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, the company has agreed to issue to the investor unregistered Series A-1 warrants to purchase up to 696,866 shares of common stock and unregistered Series A-2 warrants to purchase up to 696,866 shares of common stock. The warrants will have an exercise price of $1.435 per share and will be exercisable beginning on the effective date of stockholder approval for the issuance of the shares issuable upon exercise of the warrants. Concurrently with the registered direct offering, in a private placement priced at-the-market under Nasdaq rules, the company entered into definitive agreements with the investors for the purchase and sale of 696,866 shares of common stock, Series A-1 warrants to purchase up to 696,866 shares of the company's common stock and Series A-2 warrants to purchase up to 696,866 shares of the company's common stock at a purchase price of $1.435 per share and accompanying warrants. The warrants to be issued in the private placement will have an exercise price of $1.435 per share and will be exercisable beginning on the effective date of stockholder approval for the issuance of the shares issuable upon exercise of the warrants. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offerings. The offerings are expected to close on or about April 28, 2026, subject to satisfaction of customary closing conditions. The aggregate gross proceeds to the company from the offerings are expected to be approximately $2M, before deducting the placement agent's fees and other offering expenses payable by the company. The potential additional gross proceeds to the company from the warrants, if fully exercised on a cash basis, will be approximately $4M.
X-energy and Yesway Show Strong Debut Performance
X-energy and Yesway have both made their public debuts last week after pricing. The launches highlighted continued investor appetite across both energy innovation and everyday retail.LATEST IPOS AND DIRECT LISTINGS:X-energyopened on April 24 at $30.11. The developer of advanced small modular nuclear reactors and fuel technology for clean energy generation priced 44.25M shares at $23.00. The deal size was increased to 44.25M shares from 42.86M and priced above the $16.00-$19.00 target range.Elmetopened on April 23 at $18. The company priced 8.6M shares at $14.00 per share. The deal size was increased to 8.6M shares of common stock from 7.7M shares and priced at the high-end of the $12.00-$14.00 range. Elmet is a U.S.-based provider of precision-engineered components and advanced high-energy systems for the Aerospace, Defense and Government, Industrial, Medical, Semiconductor and Electronics, and Energy industries.Yeswayopened on April 22. The company had priced its IPO at $20 per share. Yesway is a U.S.-based convenience store operator that operates primarily under two brands, Yesway and Allsup's.National Healthcare Propertiesopened on April 22 at $11.56. The company priced 38.5M shares of its Class A common stock at $12.00 per share. National Healthcare Properties is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on senior housing and outpatient medical facilities located in the United States.Liberty Defenseopened on April 22. The company priced 3.67M shares at $4.50, the midpoint of its $4.00-$5.00 range. Liberty Defense provides multi-technology security solutions for concealed weapons detection in high volume foot traffic areas and locations requiring enhanced security such as airports, stadiums and schools.PERFORMANCE:Prices as of 11 am ET on Monday, April 27X-energy – up almost 15% at $33.57;Elmet – down about 3% at $16.57;Yesway – fractionally down at $21.64;National Healthcare Properties – fractionally up at $12.89;Liberty Defense – up almost 1% at $4.65.RECENT IPOS TO WATCH:HMH Holdingis already seeing coverage roll out, while KPET Ultra Pacelineis among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include Tarsier Pharma, Quantinuum, Cerebras, Boundless Group, and Liftoff.Clickto see upcoming IPO calendar on TipRanks.Tarsier Pharma Ltd.filed for an initial public offering of its ordinary shares and applied to list its ordinary shares on the NYSE American under the symbol "TARX". The prospectus stated: "Tarsier Pharma is developing TRS01 and TRS02, novel product candidates based on dazdotuftide, a new molecule with a new mechanism of action for uveitis and uveitic glaucoma. We are attempting to address a significant, underserved market opportunity and have engaged closely with the FDA on our clinical development strategy, including a Special Protocol Assessment agreement for our planned pivotal trial... Although we are still early in this journey, I believe we have the technology, the team, the discipline, and the persistence required to build an enduring company."Honeywellannounced thatQuantinuum, which is majority owned by Honeywell, confidentially submitted a draft registration statement on Form S-1 to the U.S. SEC on February 17, relating to the proposed initial public offering of Quantinuum's common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.Cerebras Systemsannounced that it has filed a registration statement on Form S-1 with the U.S. SEC relating to a proposed initial public offering of its Class A common stock. The number of shares of Class A common stock to be offered and the price range for the proposed offering have not yet been determined. Cerebras intends to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol "CBRS." Morgan Stanley, Citigroup, Barclays, and UBS Investment Bank will act as lead book-running managers for the proposed offering. Mizuho and TD Cowen will act as bookrunners. Needham & Company, Craig-Hallum, Wedbush Securities, Rosenblatt, and Academy Securities will act as co-managers.Boundless Groupis offering 4M Class A ordinary shares on a firm commitment basis in an initial public offering. The company expects the initial public offering price of its Class A ordinary shares to be in the range of $4.00 to $5.00 per share.Liftoff Mobileannounced that it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The total number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.OTHER IPO NEWS:Amesiteannounced that it has filed with the U.S. SEC a request for withdrawal of the company's Registration Statement on Form S-1 originally filed on April 20, as the company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the public offering described in the Registration Statement.Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.
Amesite Files for Withdrawal of S-1 Registration Statement
Amesite announced that it has filed with the U.S. SEC a request for withdrawal of the company's Registration Statement on Form S-1 (No. 333-295187) originally filed on April 20, 2026, as the company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the public offering described in the Registration Statement.
Ähnliche Artikel
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.